Can you provide the last earnings date for VAPOTHERM INC?
VAPOTHERM INC (VAPO) last reported earnings on 11/8/2023.
NYSE:VAPO • US9221073052
Past quarterly earnings results for VAPOTHERM INC (VAPO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2023 | -2.38 | -2.11 | -12.72% | 69.64% | 15.17M | 16.401M | -7.51% | 11.96% |
| Q2 2023 | -2.32 | -2.75 | 15.76% | 65.48% | 16.04M | 17.338M | -7.49% | 23.67% |
| Q1 2023 | -3.60 | -3.55 | -1.42% | 48.28% | 17.73M | 18.716M | -5.27% | -17.99% |
| Q4 2022 | -6.24 | -6.39 | 2.27% | -791.43% | 18.66M | 18.21M | 2.47% | -16.10% |
| Q3 2022 | -7.84 | -6.36 | -23.18% | -1,407.69% | 13.55M | 16.867M | -19.67% | -64.45% |
| Q2 2022 | -6.72 | -6.12 | -9.80% | -902.99% | 12.97M | 18.713M | -30.69% | -37.13% |
| Q1 2022 | -6.96 | -5.25 | -32.58% | -1,640.00% | 21.62M | 22.689M | -4.71% | -33.09% |
| Q4 2021 | -0.70 | -0.65 | -8.50% | -4.48% | 22.24M | 17.762M | 25.21% | -45.64% |
| Q3 2021 | -0.52 | -0.50 | -4.58% | -6.12% | 38.12M | 31.505M | 21.00% | 24.74% |
| Q2 2021 | -0.67 | -0.66 | -2.00% | -91.43% | 20.63M | 18.61M | 10.85% | -41.31% |
| Q1 2021 | -0.40 | -0.45 | 11.68% | 39.39% | 32.31M | 32.431M | -0.37% | 68.99% |
| Q4 2020 | -0.67 | -0.55 | -22.55% | - | 40.91M | 37.924M | 7.87% | - |
| Q3 2020 | -0.49 | -0.54 | 9.36% | - | 30.56M | 24.614M | 24.16% | - |
| Q2 2020 | -0.35 | -0.40 | 13.50% | - | 35.15M | 34.143M | 2.95% | - |
| Q1 2020 | -0.66 | -0.57 | -16.06% | - | 19.12M | 19.283M | -0.85% | - |
Notes
VAPOTHERM INC (VAPO) last reported earnings on 11/8/2023.
VAPOTHERM INC (VAPO) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, VAPOTHERM INC (VAPO) has beaten EPS estimates in 2 out of 4 releases.